NCT05577065View on ClinicalTrials.gov

A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

March 13, 2024

Study Completion Date

March 13, 2024

Conditions
Upper Respiratory Tract InfectionsUpper Resp Tract Infection
Interventions
DIETARY_SUPPLEMENT

Probiotic

Single strain probiotic in the form of a sachet with a daily dose of 3E+9 Colony Forming Unit (CFU) per day for 26 weeks.

DIETARY_SUPPLEMENT

Placebo

Matching placebo in the form of a sachet once daily for 26 weeks

Trial Locations (1)

T23 R50R

Atlantia Food Clinical Trials, Cork

Sponsors
All Listed Sponsors
collaborator

Atlantia Food Clinical Trials

INDUSTRY

lead

The Archer-Daniels-Midland Company

INDUSTRY

NCT05577065 - A Study to Assess the Effect of a Probiotic on Upper Respiratory Tract Infections in Healthy Children | Biotech Hunter | Biotech Hunter